Prestige Brands’ OTC Revenue Climbs With Boost In Advertising
This article was originally published in The Tan Sheet
Executive Summary
Prestige CEO Mannelly attributes the success of Clear Eyes, Chloraseptic, Compound W and Little Remedies to a $1 million increase in advertising and promotions. The OTC division’s net revenue soar 55.7% to $79.2 million.
You may also be interested in...
People In Brief
Williams stars in Clear Eyes campaign; industry veteran Brown joins Innovus as CFO; Mannatech makes promotions, addition; Loew heads Sanofi’s European commercial operations; Bayer HealthCare moves Schubmehl to CIO; more People In Brief.
People In Brief
Williams stars in Clear Eyes campaign; industry veteran Brown joins Innovus as CFO; Mannatech makes promotions, addition; Loew heads Sanofi’s European commercial operations; Bayer HealthCare moves Schubmehl to CIO; more People In Brief.
In Brief
Prestige Brands gains from acquisitions